AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Highlights
- 4DMedical signs new commercial contract with Integral Diagnostics
- Advanced lung imaging tech expands to more clinics across Victoria
- Continued success converting pilots into commercial deals
4DMedical (ASX:4DX), a leading innovator in medical imaging, has officially converted its pilot program with Integral Diagnostics (ASX:IDX) into a full-scale commercial agreement. This milestone marks a significant step forward in bringing cutting-edge lung imaging technology to a broader range of healthcare providers and patients across Victoria.
The agreement comes on the heels of a successful pilot initiative conducted at Lake Imaging, a subsidiary of Integral Diagnostics and one of the key diagnostic imaging providers in Australia. With this transition, 4DMedical’s proprietary CT LVAS™ technology will now be rolled out to general practitioners, respiratory specialists, and cardiologists at multiple Lake Imaging sites.
This commercial contract opens the door for more widespread clinical use of 4DMedical’s unique lung imaging solution, which is designed to deliver detailed, high-resolution insights into lung function. The CT Lung Ventilation Analysis Software (CT LVAS™) enables earlier and more accurate detection of respiratory conditions, ultimately supporting better treatment plans and improved patient outcomes.
The move reflects strong demand among clinicians for more advanced imaging tools that go beyond traditional diagnostics. By providing a non-invasive and highly detailed analysis of lung ventilation, CT LVAS™ supports a more comprehensive understanding of lung health in patients with conditions such as asthma, COPD, and other respiratory diseases.
This latest agreement also continues 4DMedical’s consistent track record of converting all pilot programs into full commercial arrangements, underscoring the clinical value and operational reliability of its technology. The collaboration with Integral Diagnostics further cements the company's position in the Australian healthcare sector and lays a foundation for further commercial partnerships both locally and internationally.
Andreas Fouras, Founder and Managing Director of 4DMedical, noted the high level of clinician interest in the company’s imaging products as a driving force behind this latest development. He highlighted the company’s mission to revolutionize lung health and the importance of expanding access to accurate and timely respiratory diagnostics.
The commercial rollout across Victoria signals growing momentum for 4DMedical (4DX) as it continues to expand its footprint in medical imaging innovation, helping redefine how lung health is assessed and managed in modern clinical practice.
